Lithium: Coronavirus

(asked on 3rd November 2020) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the research by the Translational Neuroscience Research Group et al Does Lithium Deserve a Place in the Treatment Against COVID-19?, published on 27 October, on the effects of using lithium to treat patients with COVID-19.


Answered by
Lord Bethell Portrait
Lord Bethell
This question was answered on 19th November 2020

The Department has noted the findings from this small observational study and is considering carefully all available evidence around the potential of different drugs for use in treating COVID-19, including from clinical trials in the United Kingdom and overseas.

The COVID-19 Therapeutics Taskforce is responsible for the end-to-end-provision of treatments, from clinical trials to delivery of treatments at scale to the patient population. The taskforce is closely monitoring positive signals from clinical trials to ensure that any products deemed safe and effective in treating COVID-19 can rapidly be brought into wider use across the National Health Service in the UK. The taskforce will continue to monitor lithium carbonate as further trial results become available.

Reticulating Splines